Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „either“
Suchtreffer
Begriffe & Kennungen
Lamivudine Teva · 4.5 · Substances shown to be predominately excreted either via the active organic anionic pathway, or by glomerular
Eintrag öffnenLantus · 4.5 · Beta-blockers, clonidine, lithium salts or alcohol may either potentiate or weaken the blood-glucose-lowering
Eintrag öffnenLevemir · 4.5 · Octreotide/lanreotide may either increase or decrease the insulin requirement.
Eintrag öffnenLixiana · 4.5 · ASA Co-administration of ASA (100 mg or 325 mg) and edoxaban increased bleeding time relative to either medici
Eintrag öffnenLixiana · 4.5 · NSAIDs Co-administration of naproxen and edoxaban increased bleeding time relative to either medicinal product
Eintrag öffnenM-M-RVaxPro · 4.8 · In a clinical trial, 752 children received M-M-RvaxPro, either intramuscularly or subcutaneously. The general
Eintrag öffnenMenveo · 4.5 · In adolescents (11 to 18 years of age), Menveo has been evaluated in two co-administration studies with either
Eintrag öffnenMenveo · 4.5 · In adolescents (11 to 18 years of age), Menveo has been evaluated in two co-administration studies with either
Eintrag öffnenMetalyse · 4.3 · - Significant bleeding disorder either at present or within the past 6 months - Patients receiving effective a
Eintrag öffnenMetalyse · 4.3 · - Significant bleeding disorder either at present or within the past 6 months - Patients receiving effective o
Eintrag öffnenMixtard · 4.5 · Octreotide/lanreotide may either increase or decrease the insulin requirement.
Eintrag öffnenMixtard · 4.5 · Octreotide/lanreotide may either increase or decrease the insulin requirement.
Eintrag öffnenMysimba · 4.5 · Administration of naltrexone/bupropion to patients receiving either levodopa or amantadine concurrently should
Eintrag öffnenNexium Control · 4.5 · 19 Naproxen or rofecoxib Studies evaluating concomitant administration of esomeprazole and either naproxen or
Eintrag öffnenNexium Control · 4.5 · 6 Naproxen or rofecoxib Studies evaluating concomitant administration of esomeprazole and either naproxen or r
Eintrag öffnenNovoMix · 4.5 · Octreotide/lanreotide may either increase or decrease the insulin requirement.
Eintrag öffnenNovoMix · 4.5 · Octreotide/lanreotide may either increase or decrease the insulin requirement.
Eintrag öffnenNovoRapid · 4.5 · Octreotide/lanreotide may either increase or decrease the insulin requirement.
Eintrag öffnenNuvaxovid · 4.8 · The most frequent adverse reactions after either the first or second monovalent Omicron BA.5 booster dose were
Eintrag öffnenNuvaxovid · 4.8 · The most frequent adverse reactions after either the first or second monovalent Omicron BA.5 booster dose were
Eintrag öffnen